Inhibikase Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Inhibikase Therapeutics

29/03/2023 21:16

* Inhibikase Therapeutics Inc  IKT.OQ   IKT.O  is expected
to show
a fall in quarterly revenue when it reports  results on March
31. 
    * 
    * ​Refinitiv's mean analyst estimate for Inhibikase
Therapeutics
Inc is for a loss of 19 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated March 29 at 20:16 GMT.  All
figures in US dollars  unless otherwise stated